COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection

Salvatore Iacono1† Giuseppe Schirò1† Chiara Davì1 Sergio Mastrilli2 Michelle Abbott3 Fabrizio Guajana1 Valentina Arnao4 Paolo Aridon1 Paolo Ragonese1 Cesare Gagliardo1 Claudia Colomba3 Nicola Scichilone5 Marco D’Amelio1* SARS-CoV-2 infection leading to Coronavirus disease 19 (COVID-19) rapidly became a worldwide health emergency due to…[...]

Read More

‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA

Peter I. Parry, Astrid Lefringhausen, Conny Turni, Christopher J. NeilRobyn Cosford, Nicholas J. Hudson  and, Julian Gillespie Children’s Health Research Clinical Unit, Faculty of Medicine, The University of Queensland, Biomedicines 2023, 11(8),…[...]

Read More

Biomarkers in long COVID-19: A systematic review

Front. Med., 20 January 2023 Sec. Infectious Diseases: Pathogenesis and TherapyVolume 10 - 2023 | https://doi.org/10.3389/fmed.2023.1085988 Yun-Ju Lai1*† Shou-Hou Liu2† Sumatchara Manachevakul1† Te-An Lee2,3 Chun-Tse Kuo2 Dhimiter Bello4  Purpose: Long COVID, also known as post-acute sequelae of…[...]

Read More

Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer–BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines 

Sandhya Bansal, Sudhir Perincheri, Timothy Fleming,Christin Poulson, Brian Tiffany, Ross M. Bremner;Thalachallour Mohanakumar Author & Article Information J Immunol (2021) 207 (10): 2405–2410. https://doi.org/10.4049/jimmunol.2100637 Abstract Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) causes severe…[...]

Read More